ELVN
ENLIVEN THERP (ELVN)
NASDAQ
$42.24+$0.41 (+0.99%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $3.1B
    Market Cap
  • 104.10%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
13.68%
10.0M
+3.2M (+31.88%)
Jun 30, 2026
ORBIMED ADVISORS LLC
9.25%
6.8M
-1.2M (-17.46%)
Jun 30, 2026
POLAR CAPITAL HOLDINGS PLC
8.78%
6.4M
+1.4M (+21.22%)
Jun 30, 2026
BLACKROCK, INC.
5.95%
4.4M
+674,997 (+15.48%)
Jun 30, 2026
VESTAL POINT CAPITAL, LP
5.46%
4.0M
+750,000 (+18.75%)
Jun 30, 2026
COMMODORE CAPITAL LP
4.47%
3.3M
0 (0.00%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
4.05%
3.0M
+28,486 (+0.96%)
Dec 31, 2024

Current Ownership Distribution

  • Institutions427.1M (77.19%)
  • Mutual Funds115.2M (20.81%)
  • Insiders11.1M (2.00%)
  • Other0 (0.00%)

Insider Transactions

  • 2.00% (11.1M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 10
    Number of InsiderSelling (last 12 months)
  • $1.2B
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Oct 19, 2026
$0.00
5,000
$0.00
101,268
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Oct 19, 2026
$0.00
6,018
$0.00
175,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Oct 19, 2026
$12,400.00
5,000
$2.48
30,000
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Oct 19, 2026
$89,367.30
6,018
$14.85
44,018
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Oct 19, 2026
$192,342.00
5,000
$38.47
25,000
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Oct 19, 2026
$231,545.56
6,018
$38.48
38,000
BALL KRISTINE M
Award
Oct 14, 2026
$0.00
23,394
$0.00
23,394
Garland J. Scott
Exempt
Oct 01, 2026
$0.00
13,000
$0.00
46,372
Garland J. Scott
Exempt
Oct 01, 2026
$201,110.00
13,000
$15.47
13,000
Garland J. Scott
Sell
Oct 01, 2026
$606,719.10
13,000
$46.67
0
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Sep 17, 2026
$0.00
3,982
$0.00
181,018
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Sep 17, 2026
$59,132.70
3,982
$14.85
44,018
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Sep 17, 2026
$176,851.10
3,535
$50.03
40,483
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Sep 17, 2026
$111,270.47
2,194
$50.72
38,289
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Sep 17, 2026
$14,881.45
289
$51.49
38,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Aug 17, 2026
$0.00
5,000
$0.00
111,268
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Aug 17, 2026
$270,168.37
4,630
$58.35
41,424
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Aug 17, 2026
$12,400.00
5,000
$2.48
30,000
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Aug 17, 2026
$82,382.80
1,388
$59.35
40,036
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Aug 17, 2026
$227,649.63
3,900
$58.37
26,100
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Aug 17, 2026
$65,281.15
1,100
$59.35
25,000
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
87,373
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
27,567
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
23,364
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
20,491
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$216,685.04
87,373
$2.48
87,373
Derynck Mika K
Exempt
Aug 04, 2026
$696,893.76
27,567
$25.28
114,940
Derynck Mika K
Exempt
Aug 04, 2026
$346,955.40
23,364
$14.85
138,304
Derynck Mika K
Exempt
Aug 04, 2026
$460,432.77
20,491
$22.47
158,795
Derynck Mika K
Sell
Aug 04, 2026
$9.6M
158,795
$60.21
0